首页> 外国专利> THROMBOSIS RESISTANT MECHANICAL PROSTHETIC HEART VALVE

THROMBOSIS RESISTANT MECHANICAL PROSTHETIC HEART VALVE

机译:抗血栓形成的机械人工瓣膜

摘要

Thrombosis resistant mechanical prosthetic heart valve is technical medical equipment. Thromboembolic is one of the most important complications of the available mechanical valves which may appear as a clot formation on the valve, its dysfunction, severe insufficiency or stenosis, and systemic emboli (mainly cerebral). Thus, these patients have to use anticoagulants especially Warfarin during their lifetime. INR (International Normalized Ratio) differs in these patients and it should be considered in taking medicine. However, it is not easy considering severe food and medicinal interferences in decreasing or increasing of effects of warfarin, unpredictability of its effect from one person to another and even in different times in one person, and severe variation of INR. Also, increase of INR may lead to hemorrhage of different parts of body including that of gastrointestinal system and brain. Additionally, non-therapeutic INR may lead to provide conditions for thromboembolic complications and patient's life is threatened in both cases. Therefore, continuous changes of INR serves as the strongest independent predictor of less survival rate in patients with mechanical heart valve. Using Nano technology, properties of Nano-materials and developing a Nano-pattern cover with Nanowires of Silicon dioxide (SiO2) or Zink oxide (ZnO) and Titanium dioxide (TiO2), this plan tries to create superhydrophobia as well as electrical and mechanical barriers in the outermost layer of all surfaces of the valve being in contact with blood circulation and prevent from accumulation of blood cells (platelets, red blood cells, and white blood cells) and proteins (fibrin strands) and thrombosis. In this way, thromboembolic events and colonization of bacteria on the prosthetic valve and infection of the prosthesis are prevented and it is not required to consume anticoagulants such as Warfarin.
机译:抗血栓形成的机械人工心脏瓣膜是医疗技术设备。血栓栓塞症是可用机械瓣膜最重要的并发症之一,可能表现为瓣膜上的血块形成,功能障碍,严重的供血不足或狭窄以及全身性栓塞(主要是脑部)。因此,这些患者在其一生中必须使用抗凝剂,尤其是华法林。这些患者的INR(国际标准化比率)有所不同,因此应在服药时予以考虑。但是,考虑到严重的食物和药物干扰会降低或增加华法林的作用,一个人对另一个人甚至在一个人的不同时间作用的不确定性以及INR的严重变化,这并不容易。此外,INR升高可能导致身体各个部位的出血,包括胃肠系统和大脑的出血。此外,非治疗性INR可能导致血栓栓塞并发症的发生,这两种情况都会威胁患者的生命。因此,INR的连续变化是机械性心脏瓣膜患者生存率降低的最强独立预测因子。利用纳米技术,研究纳米材料的性能,并开发出具有二氧化硅(SiO 2 )或氧化锌(ZnO)和二氧化钛(TiO 2 ),该计划试图在与血液循环接触的瓣膜所有表面的最外层形成超疏水性以及电气和机械屏障,并防止血细胞(血小板,红血球和白血球)积聚)和蛋白质(纤维蛋白链)和血栓形成。以这种方式,防止了血栓栓塞事件和人工瓣膜上的细菌定居以及假体的感染,并且不需要消耗抗凝剂例如华法林。

著录项

  • 公开/公告号WO2015189716A1

    专利类型

  • 公开/公告日2015-12-17

    原文格式PDF

  • 申请/专利权人 OJAGHIHAGHIGHI SEYEDHOSSEIN;MIKAEILPOUR AKRAM;

    申请/专利号WO2015IB52690

  • 发明设计人 MORTEZABAGI HAMIDREZA;

    申请日2015-04-14

  • 分类号A61L27/04;A61L27/06;A61L27/30;A61L31/02;A61L31/08;A61L33/02;

  • 国家 WO

  • 入库时间 2022-08-21 14:20:03

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号